首页|高通量血液透析对慢性肾脏病患者的疗效及疾病治疗功能状态的影响

高通量血液透析对慢性肾脏病患者的疗效及疾病治疗功能状态的影响

扫码查看
目的 探讨高通量血液透析(high flux hemodialysis,HFH)对慢性肾脏病(chronic kidney disease,CKD)患者的疗效及疾病治疗功能状态的影响.方法 选取福建医科大学附属第二医院 2020 年 11 月—2023 年 3 月 169 例需要血液透析的CKD患者作为调查对象,采用随机数字表法分为对照组(84例)和观察组(85 例).对照组患者给予常规血液透析治疗,而观察组患者给予HFH治疗.比较 2 组患者血液透析效果、疾病治疗功能状态、睡眠质量的差别.血液透析疗效采用尿素氮(blood urea nitrogen,BUN)、血肌酐(blood creatinine,Scr)、血清同型半胱氨酸(serum homocysteine,Hcy)、晚期糖基化终末产物(advanced glycation end products,AGEs)等指标评价.采用慢性疾病治疗功能评估-灵性量表(functional assessment of chronic illness therapy-spiritual well-being,FACIT-Sp-12)和匹兹堡睡眠质量指数(Pittsburgh sleep quality index,PSQI)评价患者的疾病治疗功能状态和睡眠质量.结果 干预后,观察组BUN、Scr水平分别为(13.13±1.70)µg/L、(209.19±23.28)μmol/L,低于对照组的(15.00±2.09)µg/L、(253.51±19.40)μmol/L,差异有统计学意义(P<0.05).干预后,观察组Hcy、AGEs水平分别为(21.78±3.19)µmol/L、(21.64±2.85)U/L,低于对照组的(24.18±3.65)µmol/L、(24.20±3.41)U/L,差异无统计学意义(P<0.05).干预后,观察组FACIT-Sp-12 评分为(38.36±3.13)分,高于对照组的(34.64±3.29)分,差异有统计学意义(P<0.05);观察组PSQI评分为(11.24±2.12)分,低于对照组的(12.28±2.09)分,差异有统计学意义(P<0.05).结论 HFH能够提高CKD患者的疗效,提高患者疾病治疗功能状态,提高睡眠质量.
Effect of High Flux Hemodialysis on Treatment Effect and the Functional Status of Disease Treatment in Patients With Chronic Kidney Disease
Objective To explore the effect of high flux hemodialysis(HFH)on chronic kidney disease(CKD)patients and the influence of disease treatment functional status.Methods A total of 169 patients with CKD requiring hemodialysis from the Second Affiliated Hospital of Fujian Medical University from November 2020 to March 2023 were selected as the investigation objects,and were divided into control group(84 cases)and observation group(85 cases)by random number table method.The control group received routine hemodialysis treatment,while the observation group received HFH treatment.The differences in hemodialysis efficacy,disease treatment functional status,and sleep quality between the two groups of patients were compared.The efficacy of hemodialysis was evaluated by blood urea nitrogen(BUN),blood creatinine(Scr),serum homocysteine(Hcy),advanced glycation end products(AGEs)and so on.The functional assessment of chronic illness therapy-spiritual well-being(FACIT-Sp-12)and the Pittsburgh sleep quality index(PSQI)were used to evaluate the patients'disease treatment function status and sleep quality.Results After intervention,BUN and Scr levels in the observation group were(13.13±1.70)µg/L and(209.19±23.28)μmol/L,respectively,lower than(15.00±2.09)µg/L and(253.51±19.40)μmol/L in the control group,the differences were statistically significant(P<0.05).After intervention,the levels of Hcy and AGEs in the observation group were(21.78±3.19)µmol/L and(21.64±2.85)U/L,respectively,lower than(24.18±3.65)µmol/L and(24.20±3.41)U/L in the control group,the differences were statistically significant(P<0.05).After intervention,the FACIT-Sp-12 score of the observation group was(38.36±3.13)points,which was higher than that of the control group(34.64±3.29)points,and the difference was statistically significant(P<0.05).The PSQI score of the observation group was(11.24±2.12)points,lower than(12.28±2.09)points of the control group,and the difference was statistically significant(P<0.05).Conclusion HFH can improve the curative effect of patients with CKD,improve the functional state of patients with disease treatment,and improve the quality of sleep.

chronic kidney diseasehigh flux hemodialysisblood urea nitrogenquality of lifefunctional status of disease treatmentsleep quality

梁艺娟、吴淑芳

展开 >

福建医科大学附属第二医院血透室,福建 泉州 362000

慢性肾脏病 高通量血液透析 尿素氮 生存质量 疾病治疗功能状态 睡眠质量

2024

中国卫生标准管理
《中国卫生标准管理》杂志社

中国卫生标准管理

影响因子:1.374
ISSN:1674-9316
年,卷(期):2024.15(4)
  • 13